SOCS2 Influences LPS Induced Human Monocyte-Derived Dendritic Cell Maturation by Hu, Jin et al.





1, Ann-Charlotte Wikstro ¨m
3, Gunnar Norstedt
1*
1Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden, 2Unit of Clinical Allergy Research, Department of Medicine Solna, Karolinska
Institute, Stockholm, Sweden, 3Department of Biosciences and Nutrition, Karolinska Institute, Stockholm, Sweden, 4Department of Trauma Orthopedic & Hand Surgery,
The First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University, Nanning, Guangxi, P.R. China
Abstract
Dendritic cells (DCs) are highly specific antigen presenting cells, which link innate and adaptive immune responses and
participate in protecting hosts from invading pathogens. DCs can be generated in vitro by culturing human monocytes with
GM-CSF and IL-4 followed by LPS induced DC maturation. We set out to study the suppressor of cytokine signaling (SOCS)
proteins during maturation and activation of human monocyte-derived DCs from peripheral blood in vitro. We found that
the expression of SOCS2 mRNA and protein is dramatically up-regulated during DC maturation. Silencing of SOCS2 using
siRNA, inhibited DC maturation as evidenced by a decreased expression of maturation markers such as CD83, co-stimulatory
molecules CD40, CD86 and HLA-DR. Furthermore, silencing of SOCS2 decreased LPS induced activation of MAP kinases
(SAKP/JNK, p38, ERK), IRF3, decreased the translocation of the NF-kB transcription factor and reduced downstream gene
mRNA expression. These results suggest a role for SOCS2 in the MyD88-dependent and -independent TLR4 signaling
pathways. In conclusion, our results demonstrate that SOCS2 is required for appropriate TLR4 signaling in maturating
human DCs via both the MyD88-dependent and -independent signaling pathway.
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Introduction
The innate immune system is the first line of defense protecting
the host from invading pathogens. Dendritic cells (DCs) serve as
highly specific APCs and play a crucial role connecting the
induction of innate immunity and the subsequent development of
the adaptive immune response [1,2]. In this process, DC
maturation serves as the critical switch from maintenance of self-
tolerance to the induction of immunity [3]. Mature DCs increase
the expression of co-stimulatory molecules, as well as MHC I and
II and diverse immune regulative molecules that stimulate naive
Th cells to differentiate into Th1 or Th2 cells [4,5]. DCs also
secrete large amounts of pro-inflammatory cytokines that activate
innate lymphocytes to kill infected cells that have been invaded by
pathogens [4,6].
DC’s recognize pathogen-associated molecular patterns by
various pattern recognition receptors. Among these receptors,
TLRs expressed on APCs, such as DCs and macrophages, serve as
key pattern recognition receptors [7]. There are 11 human and 13
mouse TLRs identified to date, and each TLR member precisely
recognizes distinct pathogen-associated molecular patterns derived
from various microorganisms and activate inflammatory cytokines,
chemokines, IFNs and upregulate the expression of co-stimulatory
molecules [1]. LPS is a gram negative bacterial cell wall
component and a TLR4 ligand [8,9]. Ligand-induced dimeriza-
tion activates the TLR4, and adapters are recruited via their Toll-
interleukin 1 receptor (TIR) domains. MyD88 is a universal
adaptor and acts to recruit the interleukin 1-associated kinas
(IRAK) family, TNF receptor-associated factor (TRAF) 6 and
IkBa kinases which leads to the activation of the transcription
factor, NF-kB and also MAP kinases (JNK, p38, ERK) [10].
MyD88-adaptor like (MAL) is also recruited by TLR4 and
stabilize MyD88 in the complex [10]. The above pathway is
termed the MyD88-dependent pathway. In addition the MyD88-
independent signaling pathway activates a TIR domain-contain-
ing adaptor (TRIF), which needs another bridge adaptor, the
TRIF-related adaptor molecule (TRAM), and this leads to
activation of TRAF3 that contributes to the activation of
interferon regulatory factor (IRF) 3 [10,11] and the late phase
activation of NF-kB and MAP kinases [12].
Monocytes have been shown to be important DC precursor cells
both in vitro and in vivo [13,14]. Monocyte-derived DCs can be
generated by monocyte cultivation with GM-CSF and IL-4
[15,16] or IL-13 [17] in vitro, and this makes it possible to
generate large quantities of DCs providing a model to investigate
the effect of self or environmental agents on the differentiation and
maturation pathways of DCs.
Suppressor of cytokine signaling (SOCS) family includes eight
members, characterized by the presence of a Src homology 2
domain and a C-terminal conserved domain called the SOCS box
[18], Each family member plays a unique role in attenuating
cellular signaling [19,20]. SOCS1 and SOCS3 have recently been
demonstrated to negatively regulate TLR signaling in macrophage
and DC maturation [21,22,23]. Although SOCS2 is a well known
PLoS ONE | www.plosone.org 1 September 2009 | Volume 4 | Issue 9 | e7178negative regulator of some signaling pathways such as the JAK/
STAT pathway [24], there is little knowledge about the role of
SOCS2 in TLR signaling. One study has demonstrated that
SOCS2 mRNA expression increased during differentiation and
maturation of mouse DCs [25], which suggested a possible SOCS2
involvement in DC function, but subsequent over-expression of
the SOCS2 protein did not influence TLR signaling in mouse
macrophages [26]. Another study showed that SOCS2 might be
involved in the regulation of the immune response upon infection.
SOCS2 mRNA and protein were induced by lipoxin (LXA4), an
eicosanoid mediator with potent anti-inflammatory properties in
DCs, and SOCS2 knock-out mice showed decreased microbial
proliferation, leukocyte infiltration, production of pro-inflamma-
tory cytokines, and a high mortality upon infection [27]. These
findings suggest that SOCS2 may have an important role in the
immune response to diverse infectious agents.
In this study, we generated DCs from human monocytes
cultured with GM-CSF and IL-4 and used them to investigate the
role of SOCS proteins and TLR4 signaling pathways in DC
maturation.
Results
Gene expression of SOCS family members during
maturation of human monocyte-derived DCs
Previous studies have shown that cytokine-inducible SH2-
domain protein (CIS), SOCS1, SOCS2 and SOCS3 gene
expressions are regulated by LPS stimulation in mouse DCs or
macrophages [25,26]. In addition, IL21 [28] and protein allergens
[29] can change expressions of SOCS 1 and SOCS 3 in humans
DCs. We first studied the gene expression of SOCS members
during DC maturation. Human monocyte-derived immature DCs
(iDCs) were obtained by culturing with GM-CSF and IL-4.
Subsequently the cells were treated with LPS at day 6 of
differentiation and harvested for mRNA measurement after
24 h. As shown in Fig. 1A, SOCS2, SOCS3 and SOCS6 changed
significantly after LPS treatment, whereas the other SOCS family
members CIS, SOCS1, 4 and 5 did not change in expression
levels. Based on the regulatory changes of SOCS2 mRNA
expression in our experiment, we decided to further focus on the
role of SOCS2 in the process of DC maturation. Real-time PCR
analysis of total RNA revealed that SOCS2 mRNA levels start to
increase at 2 h after LPS treatment and became significant from
4 h till 24 h (Fig. 1B). Western Blotting analysis of whole cell
protein extracts showed that also SOCS2 protein levels increased
after LPS treatment in a manner that corresponded to the changes
seen in mRNA levels. The effect was weak at 4 h, but became
significant at 8 h and increased dramatically up to 16 h where the
expression was sustained for at least 24 h (Fig. 1C, D).
SOCS2 influences MyD88-dependent and MyD88-
independent signaling in the TLR4 signaling pathway
LPS affects iDC function through activation of the TLR4
signaling pathway, which downstream consists of the MyD88-
dependent and the TRIF-dependent pathway, the latter is also
called the MyD88-independent pathway [11]. First, we wanted to
test whether SOCS2 induced by LPS can affect the TLR4
signaling pathway. A specific silencing RNA (siRNA) targeting
human SOCS2 or negative control siRNA with no homology to
any known mammalian gene were transfected into iDC, and
SOCS2 mRNA expression was then monitored. Low expression
levels of SOCS2 was detected in untreated DCs, and as expected
LPS treatment induced SOCS2 expression in control cells, an
Figure 1. Expressions of SOCS family members during human
monocyte-derived DC maturation. (A). mRNA expression of SOCS
family members during DC maturation. Enriched monocytes were
cultured in the presence of GM-CSF and IL-4 for 6 days. Quantitative
real-time PCR was used to measure SOCS mRNA expression in iDC at d6
and at d7, after exposure to LPS for 24 h. Data shown are the mean of
duplicate determination from four donors, fold changes were obtained
by comparing effects before and after of LPS treatment. (B, C, D). SOCS2
mRNA and protein expression levels during iDC maturation. Quantita-
tive real-time PCR for mRNA and Western Blotting analysis for protein of
SOCS2 expression in iDCs exposed to LPS for different time periods. The
data shown in (B) are the mean of triplicate determination from four
donors. Values for 0 time point were set to 1. The picture shown in (C)
represents one Western Blot from a typical donor sample. The data
shown in (D) are the mean of SOCS2 bands quantified from Western
blots and normalized to b-actin from four donors. Values for 0 time
point were set to 1. Error bars illustrate s.d. * P,0.05; ** P,0.01.
doi:10.1371/journal.pone.0007178.g001
SOCS2 and DC Maturation
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cells both at the level of mRNA (Fig. 2A) and protein (Fig. 2B, C).
To study the effect of SOCS2 on the MyD88-dependent
signaling pathway, proteins from control or SOCS2 siRNA
transfected DCs were extracted. LPS activation of this pathway
results in a cascade of kinase dependent phosphorylations. The
kinetics of the phosphorylation of SAKP/JNK, P38, ERK and
IkBa was measured by Western Blotting. In cells with SOCS2
siRNA, LPS treatment led to a reduced phosphorylation of
SAKP/JNK, P38, ERK and IkBa (Fig. 3A). When nuclear
proteins were extracted from control or SOCS2 siRNA treated
DCs the SOCS2 silenced DCs displayed a weaker NF-kB band
compared to control DCs (Fig. 3B). This indicates that less NF-kB
was translocated into the nucleus after SOCS2 elimination,
supporting the notion that SOCS2 silencing inhibits the
MyD88-dependent signaling pathway in human DCs by inter-
rupting the normal SOCS2 dependent kinase cascade.
Protein extracts from control or SOCS2 siRNA transfected DCs
were then tested for the effect of SOCS2 on the MyD88-
independent signaling pathway. IRF3, a kinase that is phosphor-
ylated and translocated into the nucleus following LPS stimulation,
was phosphorylated to a lesser extent in the SOCS2 knock-down
DCs (Fig. 3C). This supports the notion that TLR4 signaling is
SOCS2 dependent in human DCs, not only via the MyD88-
dependent but also via the MyD88-independent signaling
pathway. In initial studies, we tested two different SOCS2 siRNAs
having different sequences. These experiments showed that there
were no differences in the extent of SOCS2 reduction and effect
between the two SOCS2 siRNAs. For this reason we selected one
SOCS2 siRNA in subsequent experiments.
LPS induced gene expression is dependening on SOCS2
Activation of the TLR4 signaling pathway induces, for example,
TNF-a, IL-6, IL-1b and CCL-4 via the MyD88-dependent
pathway [30,31] and IFN-b, CXCL-9, and CXCL-10 via the
MyD88-independent pathway [32,33]. To investigate if the
inhibition of TLR4 signaling by SOCS2 silencing caused
subsequent changes in mRNA expression levels of downstream
mediators in this pathway, we measured LPS inducible gene
expression by quantitative PCR. SOCS2 knock-down significantly
decreased mRNA expression of TNF-a, IL-6, IL-1b and CCL-4
(Fig. 4A), and similar effects were seen on the expression of INF-b,
CXCL-9, and CXCL-10 (Fig. 4B). These findings suggests that
SOCS2 influences LPS inducible gene expression via both the
MyD88-dependent and independent signaling pathway.
Role of SOCS2 in DC maturation in response to
inflammatory signals
As the LPS effect on DC maturation is mediated via TLR4
signal transduction we decided to investigate a possible role of
SOCS2 in DC maturation. SOCS2 knock-down DCs were
stimulated with LPS 24 h after siRNA transfection and harvested
for flow cytometry analysis. LPS stimulation of SOCS2 siRNA
transfected iDCs led to an impairment in DC maturation. This
was demonstrated by changes in surface molecule expression.
CD83, the marker for mature DCs [34], was significantly
decreased in SOCS2 siRNA transfected DCs. Moreover, these
DCs showed a weaker expression of the co-stimulatory molecules
CD40, CD86, whereas no evident effect on CD80 and HLA-DR
was demonstrated, based on the percentage of positive cells (%
positive cells) compared with control group (Fig. 5). Cells
transfected with SOCS2 siRNA showed a decrease in mean
fluorescence intensity around 40%, for the CD83 marker and
Figure 2. SOCS2 siRNA inhibits SOCS2 mRNA and protein
expression in DCs during maturation. Enriched monocytes were
cultured in the presence of GM-CSF and IL-4 for 6 days. iDCs were
transfected with SOCS2 siRNA or control siRNA and incubated for
24 hours. (A). SOCS2 mRNA gene expression from DC transfected with
SOCS2 silencing RNA during maturation. Transfected cells were
exposed to LPS (200 ng/ml) for 2 hours, the cells were then harvested
for the measurement of SOCS2 RNA expression by qRT-PCR. Data
shown were mean of duplicate determination from 4 donors. (B, C).
SOCS2 protein level expression from DCs transfected with SOCS2
silencing RNA during maturation. Transfected cells were exposed to LPS
(200 ng/ml) for 8 hours, after which whole-cell lysates were extracted
for the measurement of SOCS2 protein levels by Western Blotting. (B)
Picture shown is 1 of 4 typical donors. (C) Data shown are mean of
SOCS2 bands quantified and normalized to b-actin from four donors.
Values for the control were set to 1. Error bars illustrate s.d. * P,0.05; **
P,0.01.
doi:10.1371/journal.pone.0007178.g002
SOCS2 and DC Maturation
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control cells (data no shown).
Discussion
Our data confirm and further extend the knowledge of SOCS
involvement in DC maturation [25,26] and indicate that SOCS2
is an important SOCS family member involved in the maturation
process. This was demonstrated by a clear increase of both SOCS2
mRNA and protein during DC maturation and the finding that
SOCS2 silencing leads to an impaired maturation of DCs. LPS
stimulation of iDCs where SOCS2 had been silenced failed to
express CD83, a typical marker of DC maturation. In addition,
such cells showed a lower expression of the co-stimulatory
molecules CD40, CD86 and HLA-DR. We showed that SOCS2
silencing decreased both MyD88-dependent and -independent
signaling in the TLR4 signaling pathway. This finding was
corroborated by a corresponding decrease of LPS inducible genes
encoding the effector cytokines TNF-a, IL-6, IL-1b and CCL-4. A
SOCS2 dependency was also demonstrated for gene expression of
INF-b, CXCL-9 and CXCL-10 i.e. genes related to the MyD88-
independent signaling pathway. LPS stimulation under conditions
of SOCS2 knock-down resulted in a decreased expression of all of
these genes. Our results were substantiated at the protein level by
Western Blots of protein extracts. Down-regulation of SOCS2 led
to a decrease in NF-kB nuclear translocation in response to LPS
stimulation [35] and also the phosphorylation of IRF3 [36] and
the activation of MAP kinases [37] was reduced in LPS stimulated
cells where SOCS2 had been silenced. Thus, SOCS2 regulates
TLR signaling via the MyD88-dependent and -independent
signaling pathway.
SOCS2, as other members of this family is thought to function
as a subunit of an E3 ubiquitin ligase complex [38]. The SOCS
box, placed at the C-terminus serves to interact with Elongins C
and B, cullin5 and Rbx2 forming the catalytic core of the complex
[39,40]. The SH2 domain of SOCS2 serves to interact with
phosphotyrosine residues the targeted substrate directing the
specificity of the ubiquitin ligase reaction [39]. For other members
of the family it has been demonstrated that SOCS targets are
polyubiquitinated and subsequently degraded by the proteasome
[40,41]. Consequently, the most common effect of SOCS proteins
is to reduce signaling. In dendritic cells, this is the case with
SOCS3 and SOCS1, which have been shown to inhibit TLR
signaling targeting TRAF6 in the case of SOCS3 [42] and MAL in
the case of SOCS1 [43]. In contrast, SOCS2 elimination reduce
LPS induced signals suggesting that negative regulators of TLR4
signaling are themselves targeted for degradation by SOCS2. Such
negative regulators should themselves be tyrosine phosphorylated
in order to interact with SOCS2. Interestingly, SOCS2 can
control levels of other SOCS proteins such as SOCS3 and SOCS1
[44], and such interactions may explain why LPS signaling is
diminished in the absence of SOCS2. Other SOCS proteins are
not the only possible targets and proteins such as DNAX-
activating protein 12 [45] and the Tyro3/Axl/Mer family of
receptor kinases [46] have been shown both to be tyrosine
phosphorylated as well as to act as negative regulators of TLR
signaling. Interestingly, both of these pathways target MAL an
early signaling intermediaries in the TLR signaling cascade.
Because both the MAL/MyD88 and the TRAM-TRIF pathways
are both affected by SOCS2 knock-down, it seems plausible that
SOCS2 targets act early on the signaling pathway, in line with
possible actions of SOCS1 or the Tyro3/Axl/Mer receptor family.
In a more complex scenario, it is possible that SOCS2 has separate
targets for MyD88 dependent and independent pathways. In this
case several negative regulators such as Src homology 1-containing
tyrosine phosphatase 1 which targets IRAK1 [47], Src homology
2-containing tyrosine phosphatase which targets TANK binding
kinase 1 [48] and mitogen-activated protein kinase phosphatase-1
Figure 3. SOCS2 siRNA inhibits TLR4 signaling of DC via inhibition of both MyD88-dependent (A, B) and -independent pathway
(C). Enriched monocytes were cultured in the presence of GM-CSF and IL-4 for 6 days. iDCs were transfected with SOCS2 siRNA or control siRNA and
incubated for 24 hours. (A). SOCS2 knock-down effect on phosphorylation of SAKP/JNK, P38, ERK and IkBa. Transfected cells were stimulated with
LPS at the indicated time points. The level of phosphorylation of SAKP/JNK, P38, ERK and IkBa was determined by Western Blotting of whole-cell
lysates using antibodies specific for the phosphorylated, activated forms of the proteins. The levels of total ERK was determined as loading controls.
(B). SOCS2 knock-down effect on nuclear translocation of NF-kB. Transfected cells were stimulated with LPS at the indicated time points. Nuclear
protein was extracted for Western Blotting measurement. The level of P65 NF-kB and Lamin A (as loading control) was detected. (C). SOCS2 knock-
down effect on phosphorylation of IRF3. Transfected cells were stimulated with LPS at the indicated time points. The level of phosphorylated and
total IRF3 was determined by Western Blotting of whole-cell lysates using antibodies specific for the forms of the proteins, respectively. The IRF3
bands were quantified, and the ratio of phosphorylated to total IRF3 were shown.
doi:10.1371/journal.pone.0007178.g003
SOCS2 and DC Maturation
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possibilities. Obviously this is a complex problem that requires a
careful examination in future studies. It is important to note that
SOCS2 is known to have stimulatory activity on certain cytokine
signaling pathways. It can increase the action of IL-6, an effects
that has been attributed to SOCS2 reversing the inhibitory action
of SOCS1 on IL-6 signaling [50]. This phenomenon may also
affect the activity of cytokines produced during dendritic cell
maturation that have a positive feed back on the process.
Animal experiments support a role for SOCS2 in immune
regulatory pathways. Mice where the SOCS2 gene has been
ablated demonstrate an increased inflammation and mortality
during T.gondii infection [27]. However, LPS treatment of splenic
DCs of SOCS2 knock out mice did not influence proinflammatory
Figure 4. SOC2 siRNA affects LPS inducible gene expression
both in the MyD88-dependent and -independent signaling
pathway. Enriched monocytes were cultured in the presence of GM-
CSF and IL-4 for 6 days. iDCs were transfected with SOCS2 siRNA or
control siRNA and incubated for 24 hours. Cells were further incubated
with LPS (200 ng/ml) for additional 2 h. LPS inducible gene mRNA
expressions were measured by real-time PCR. (A). LPS inducible gene
expression of TNF-a, IL-6, IL-1b and CCL-4 via the MyD88-dependent
signaling pathway. (B) LPS inducible gene expression of IFN-b, CXCL-9,
CXCL-10 via the MyD88-independent signaling pathway. Data shown
are the mean of triplicate sample, and are representative of at least two
donors with similar results. Values for the control were set to 1. Error
bars illustrate s.d. * P,0.05; ** P,0.01.
doi:10.1371/journal.pone.0007178.g004
Figure 5. Effect of SOCS2 siRNA in DC maturation. Enriched
monocytes were cultured in the presence of GM-CSF and IL-4 for
6 days. iDCs were transfected with SOCS2 siRNA or control siRNA and
incubated for 24 hours. Histograms showing the effect of SOCS2 knock-
down on DC maturation. LPS (200 ng/ml) was added and were present
for 24 hours. Afterwards, cells were harvested, stained, and analyzed by
flow cytometry. The histogram shows changes of indicated surface
molecules in DCs from the different groups. Matched isotype controls
are presented as solid histograms. Percentage of positive cells is
indicated in the upper right corner of each histogram.
doi:10.1371/journal.pone.0007178.g005
SOCS2 and DC Maturation
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LPS could not change baseline levels of MAP kinases family, but
caused a slight decrease in IkBa [51]. The reason why DC cells
from SOCS2 knock out animals seem to respond differently from
human cells is unclear. The fact that mature DCs in mice instead
of immature DCs in humans were treated with LPS might explain
the absence of LPS reactivity in DCs from SOCS2 knock out mice.
Alternatively, it may exists a functional difference between human
and mouse DCs regarding SOCS2.
In conclusion, our results indicate that SOCS2 positively
regulates maturation of human DCs in vitro. This is achieved by
promotion of TLR4 signaling through both the MyD88-
dependent and -independent signaling pathway.
Materials and Methods
Ethics Statement
The procedure of human PBMCs isolation was performed
following approval by the Ethics Committee of the Karolinska
Institute and Karolinska University Hospital.
Cell culture media and reagents
L-glutamine, penicillin, streptomycin and FCS (Hyclone,
Logan, UT); Ficoll-Paque (Pharmacia Biotech, Uppsala, Sweden);
RPMI-1640 cell culture medium and LPS derived from
Escherchia coli O26: B6 (Sigma-Aldrich, St Louis, USA);
Recombinant human GM-CSF and recombinant human IL-4
(Invitrogen Biosource, Camarillo, CA); and CD14
+ Human
monocyte isolation kit II (Miltenyi Biotec, Bergisch Gladbach,
Germany) were purchased from the sources indicated.
Generation of human monocyte-derived DCs
Human PBMCs were isolated from fresh heparinized blood
buffy coats (not older than 8 hours) from healthy donors provided
from the Department of Transfusion Medicine, Karolinska
University Hospital, by a standard procedure of Ficoll-Paque
density gradient centrifugation. CD14
+ cells were negatively
selected by MACS, according to the manufacturer’s instructions.
The mean purity of the obtained CD14
+ cells was more than 95%,
as revealed by flow cytometry. CD14
+ cells were subsequently
cultured in cell culture flasks (10
6cells/ml) and in complete
RPMI1640 medium supplemented with 10% heat-inactivated
FCS, 2 mM L-glutamine, 100U penicillin and 100U streptomy-
cin/ml, 50 ng/ml GM-CSF and 20 ng/ml IL-4 for 6 days. The
cells were fed with fresh medium (half original medium volume)
containing 100 ng/ml GM-CSF and 40 ng/ml IL-4 on days 2 and
4. Mature DCs were obtained from immature DCs (5610
5/ml),
cultivated for 6 days as described above, by stimulation with
200 ng/ml LPS for 24 h after a first incubation for 2 h in fresh
supplemented RPMI 1640 medium with 50 ng/ml GM-CSF and
20 ng/ml IL-4.
Transfection
Transfection of immature DCs (iDCs) was performed using a
commercial kit and a nucleofector machine (Amaxa Co., Ko ¨ln,
Germany). According to the manufacturer’s instruction, the iDCs
were collected on day 6. 10
7 cells were resuspended in 100 ml
human DC nucleofection solution. Small interfering RNA (siRNA)
(Qiagen, sequences in Table S1, The control siRNA and the
SOCS2 siRNAs were tested in control experiments for effects on
mRNA expression of IFNb and IFNa1 measured by Real-time
PCR. In a time course study we could not observe any effect on
IFNa1 and IFNb, whereas a robust induction was seen by
exposing cells to Poly I:C. IFNb expression was slightly increased
by the transfection method however this increase was marginal
compared to the effect of LPS on IFNb expression.) was added,
and the mixed samples were transferred into certified cuvettes and
transfected by using program U002. 500 ml pre-warmed RPMI
1640 medium, supplemented with 10% FCS, L-glutamine,
penicillin and streptomycin, was added to each cuvette after
transfection. The transfection efficiency of siRNA was measured
with Alexa Fluor 488 labeled negative control and Alexa Fluor 488
labeled SOCS2 siRNA and FACS, and it is shown to be near
100% in our experiments (data no shown). The transfected cells
were collected and seeded into wells of 6-well plates containing
supplemented RPMI 1640 medium with 50 ng/ml GM-CSF and
20 ng/ml IL-4. After 24 hours, the cells were washed and divided
into several dishes for stimulation and analysis.
Real-time PCR
Total RNA was extracted from 123610
6 cells using TRIzol
(Invitrogen). RNA (1 mg) was treated with DNase I (Promega,
Madison, WI) and then reverse-transcribed with a cDNA synthesis
kit (Bio-Rad, Hercules, CA). The synthesized cDNA was used as
template in a real-time PCR mix according to the manufacturer’s
standard protocol (iQ SYBR Green supermix reagents and iQ5
detection system from Bio-Rad, Hercules, CA). The reactions
were performed in 20 ml with 2 ml of respective cDNA sample. As
a control for the specificity of the real-time PCR a sample without
template was included. For each studied gene, a relative standard
curve was constructed by serial dilutions using a pool of all cDNA
samples. All the measurements were performed in duplicate or
triplicates for each sample and normalized to the housekeeping
genes RP-II. All primer sequences are provided in Table S2.
Flow cytometry
Antibodies for staining of human DCs were CD14 (FITC;
M5E2), HLA-DR (PerCP; L243), CD 40 (APC; 5C3), CD 80 (PE;
L307.4), CD 83 (PE; HB15), CD 86 (APC; B70) (BD Pharmingen,
NJ, USA) and CD1a (Pacific blue; HI149) (Bioscience, San Diego,
CA). Approximately 5610
5 DCs were harvested and stained with
antibodies for 30 minutes according to standard protocols. After
the incubation, the cells were washed with FACS buffer and fixed
in diluted FACS lysing solution 10 minutes and finally suspended
in 500 ml of FACS buffer. For multiple colors marker staining, the
cells were incubated with the combination of FITC-conjugated
CD14, Pacific Blue-conjugated CD1a, PE-conjugated CD83 and
APC-conjugated CD86, alternatively with APC-conjugated
CD40, PE-conjugated CD80 and PerCP-conjugated HLA-DR.
Thirty thousand cells were acquired and analyzed on a FACS
Arial flow cytometer (BD Biosciences, Heidelberg, Germany). An
appropriate gate was set on the basis of scatter properties for
excluding dead cells, and only cells within this gate were analyzed.
Cells exhibiting a higher mean fluorescence intensity value than
cells stained with respective isotype control were considered
positive.
Nuclear and cytoplasmic extraction and whole-cell
lysates
iDCs were resuspended in complete RPMI 1640 medium and
treated with LPS for different periods. After washing once with
cold PBS, nuclear and cytoplasmic protein were extracted from
5610
6 DCs using a commercial nuclear and cytoplasmic protein
extraction kit (Pierce Biotechnology, Rockford, IL) according to
the manufacturer’s instruction. To obtain whole protein lysates,
cells were incubated with radio immune precipitation assay buffer
(containing 100 ml/ml of a protease inhibitor cocktail solution
SOCS2 and DC Maturation
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minutes.
Western blotting
The cell lysates (25–40 mg total protein or 15 mg nuclear protein
per lane) were submitted to SDS- PAGE (on 12% gels), transferred
to polyvinylidenediflouride membranes for Western Blot analysis.
After blocking with 5% fat-free dried milk or BSA dissolved in
TBS-T for 1 h at room temperature, membranes were incubated
over night with antibodies raised against phosphorylated SAPK/
JNK, p38, ERK, IkBa, IRF3 and total IRF3, SOCS2(Cell
Signaling Technology, Beverly, MA) and p65NF-kB (BD Biosci-
ences, Heidelberg, Germany) respectively according to the
manufacturer’s instructions. Binding of these primary antibodies
was visualized with goat anti-rabbit/anti-mouse immunoglobulin
coupled to horseradish peroxidase (Santa Cruz biotechnology, CA,
USA). After stripping, the membranes were incubated and re-
probed for new antibodies. Measurement of total ERK, IRF3 and
b-actin protein served as loading controls.
Statistical analysis
Statistical comparisons between groups were made by analysis
of variance followed by T-test or Fisher’s post-hoc test; p-values
,0.05 were considered significant.
Supporting Information
Table S1 Oligonucleotide sequences used for siRNA
Found at: doi:10.1371/journal.pone.0007178.s001 (0.03 MB
DOC)
Table S2 Oligonucleotide sequences used for real-time PCR
Found at: doi:10.1371/journal.pone.0007178.s002 (0.05 MB
DOC)
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